NCT01055366 - ELAZOP Switching Study in Korea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Open Angle Glaucoma

Interventions

DRUG

Elazop (Azarga)

Administer one drop of ELAZOP in treated eye(s) twice a day for up to 12 weeks

Trial Locations (10)

Youngnam Univ. Hospital, Daegu

Seoul National University Bundang Hospital, Sungnam

Seoul National University Hospital, Seoul

Yonsei University Severance Hospital, Seoul

Samsung Medical Center, Seoul

Yonsei University Kangnam Severance Hospital, Seoul

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

Asan Medical Center, Seoul

Kim's Eye Hospital, Seoul

St. Mary's Hospital, The Catholic University of Korea, Seoul